Expert consensus on the use of omalizumab in chronic urticaria in China-Reference-Cited by-全球学者库

Expert consensus on the use of omalizumab in chronic urticaria in China

Published:2021-11 Issue:11 Volume:14 Page:100610
ISSN:1939-4551
Container-title:World Allergy Organization Journal
language:en
Short-container-title:World Allergy Organization Journal

Author:

Zhao Zuotao^ORCID,Cai Tao,Chen Hong,Chen Liuqing,Chen Yudi,Gao Xiang,Gao Xinghua,Geng Songmei,Guo Yinshi,Hao Fei,Hao Guodong,Hu Yan,Jin Hongzhong,Jin Zhehu,Li Chengxin,Li Haili,Li Jie,Li Yanming,Liang Yunsheng,Liu Guanghui,Liu Qiang,Long Hai,Ma Lin,Shang Yuanyuan,Song Yuxin,Song Zhiqiang,Su Xiangyang,Sui Haijing,Sun Qing,Sun Yuemei,Tang Jianping,Tong Xunliang,Wang Huiying,Wang Gang,Wang Lianglu,Wang Siqin,Xiang Li,Xiao Ting,Xie Zhiqiang,Ye Leping,Yu Yongmei,Zhang Chunlei,Zhang Litao,Zhang Shuchen,Zheng Rui,Zhi Lili,Zhou Wei,Zou Ying,Maurer Marcus

Publisher

Elsevier BV

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Reference82 articles.

1. The eaaci/ga2len/edf/wao guideline for the definition, classification, diagnosis and management of urticaria;Zuberbier;Allergy,2018

2. Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis;Fricke;Allergy,2020

3. Stress, psychiatric co-morbidity and coping in patients with chronic idiopathic urticaria;Chung;Psychol Health,2010

4. The prevalence of atopic dermatitis and chronic spontaneous urticaria are associated with parental socioeconomic status in adolescents in China;Xiao;Acta Derm Venereol,2019

5. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the aware study;Maurer;Clin Exp Allergy,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Review and Critical Appraisal of Urticaria Clinical Practice Guidelines: A Global Guidelines in Dermatology Mapping Project (GUIDEMAP);The Journal of Allergy and Clinical Immunology: In Practice;2023-10

2. Comparative effectiveness and safety of drug therapy for chronic urticaria: a network meta-analysis and risk-benefit assessment;Expert Opinion on Drug Safety;2023-09-25

3. Safety and efficacy of omalizumab for antihistamine-resistant chronic urticaria in children: a case series and literature review;World Journal of Pediatrics;2023-09-19

4. Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients;Acta Dermato-Venereologica;2023-08-30

5. Omalizumab's efficacy and safety against chronic spontaneous urticaria;World Allergy Organization Journal;2023-08